Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Dec 12, 2007 PRIMARY DOCUMENT
8-K Dec 5, 2007 FORM 8-K
8-K Dec 3, 2007 FORM 8-K
8-K Nov 29, 2007 FORM 8-K
10-Q Nov 14, 2007 FORM 10-Q
8-K Nov 2, 2007 FORM 8-K
8-K Oct 25, 2007 FORM 8-K
424B5 Oct 25, 2007 FINAL PROSPECTUS SUPPLEMENT MATERIALS
8-K Oct 25, 2007 FORM 8-K
S-3MEF Oct 25, 2007 FORM S-3MEF
8-K Oct 9, 2007 FORM 8-K
424B5 Oct 5, 2007 PRELIMINARY MATERIALS
EFFECT Sep 26, 2007
CORRESP Sep 25, 2007
CORRESP Sep 24, 2007
S-3/A Sep 24, 2007 AMENDMENT NO. 2 TO FORM S-3
S-3/A Sep 24, 2007 AMENDMENT NO. 1 TO FORM S-3
8-K/A Sep 20, 2007 PROTALIX BIOTHERAPEUTICS INC.
8-K Sep 19, 2007 PROTALIX BIOTHERAPEUTICS, INC.
8-K Aug 27, 2007 FORM 8-K
10-Q Aug 16, 2007 FORM 10-Q
NT 10-Q Aug 15, 2007 NT 10-Q
8-K Aug 10, 2007 FORM 8-K
UPLOAD Aug 7, 2007
8-K Aug 6, 2007 FORM 8-K
← Newer Page 33 of 38 · 935 filings Older →